JPWO2020069037A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020069037A5 JPWO2020069037A5 JP2021516924A JP2021516924A JPWO2020069037A5 JP WO2020069037 A5 JPWO2020069037 A5 JP WO2020069037A5 JP 2021516924 A JP2021516924 A JP 2021516924A JP 2021516924 A JP2021516924 A JP 2021516924A JP WO2020069037 A5 JPWO2020069037 A5 JP WO2020069037A5
- Authority
- JP
- Japan
- Prior art keywords
- light
- optical element
- waveguide
- coupling
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003287 optical effect Effects 0.000 claims description 1831
- 238000010168 coupling process Methods 0.000 claims description 1605
- 238000005859 coupling reaction Methods 0.000 claims description 1605
- 230000008878 coupling Effects 0.000 claims description 1587
- 230000003190 augmentative effect Effects 0.000 claims description 36
- 210000003128 head Anatomy 0.000 claims description 33
- 230000010287 polarization Effects 0.000 description 415
- 210000001525 retina Anatomy 0.000 description 282
- 238000003384 imaging method Methods 0.000 description 182
- 238000005286 illumination Methods 0.000 description 150
- 239000004973 liquid crystal related substance Substances 0.000 description 130
- 210000004087 cornea Anatomy 0.000 description 91
- 238000013461 design Methods 0.000 description 74
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 description 55
- 239000002131 composite material Substances 0.000 description 45
- 230000004256 retinal image Effects 0.000 description 45
- 238000012545 processing Methods 0.000 description 41
- 238000000034 method Methods 0.000 description 33
- 239000000463 material Substances 0.000 description 29
- 230000002829 reductive effect Effects 0.000 description 26
- 238000000576 coating method Methods 0.000 description 25
- 239000011248 coating agent Substances 0.000 description 24
- 239000003086 colorant Substances 0.000 description 21
- 230000001419 dependent effect Effects 0.000 description 19
- 210000001747 pupil Anatomy 0.000 description 15
- 238000005259 measurement Methods 0.000 description 14
- 230000002207 retinal effect Effects 0.000 description 14
- 230000001902 propagating effect Effects 0.000 description 13
- 238000004891 communication Methods 0.000 description 12
- 241000153282 Theope Species 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000000835 fiber Substances 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 206010034962 Photopsia Diseases 0.000 description 9
- 239000006185 dispersion Substances 0.000 description 9
- 229910000065 phosphene Inorganic materials 0.000 description 9
- 238000009826 distribution Methods 0.000 description 8
- 239000013307 optical fiber Substances 0.000 description 8
- 238000006073 displacement reaction Methods 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 238000013507 mapping Methods 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000004313 glare Effects 0.000 description 6
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 5
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 5
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 5
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 5
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 5
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 5
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 5
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 5
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 5
- 230000004308 accommodation Effects 0.000 description 5
- 230000002350 accommodative effect Effects 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000003098 cholesteric effect Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000008447 perception Effects 0.000 description 5
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 4
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 4
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 4
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 4
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 4
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 4
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 4
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 4
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000006117 anti-reflective coating Substances 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000005253 cladding Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000004424 eye movement Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 239000011295 pitch Substances 0.000 description 4
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 4
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 4
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 2
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 2
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 2
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 2
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 2
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000000613 ear canal Anatomy 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001429 visible spectrum Methods 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 206010027646 Miosis Diseases 0.000 description 1
- 208000006550 Mydriasis Diseases 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- 239000004983 Polymer Dispersed Liquid Crystal Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000003708 edge detection Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- SQEHCNOBYLQFTG-UHFFFAOYSA-M lithium;thiophene-2-carboxylate Chemical compound [Li+].[O-]C(=O)C1=CC=CS1 SQEHCNOBYLQFTG-UHFFFAOYSA-M 0.000 description 1
- 230000003547 miosis Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023172745A JP2023171481A (ja) | 2018-09-26 | 2023-10-04 | ピンホールおよびスリットカメラを伴うアイウェア |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862737063P | 2018-09-26 | 2018-09-26 | |
| US62/737,063 | 2018-09-26 | ||
| US201862737817P | 2018-09-27 | 2018-09-27 | |
| US62/737,817 | 2018-09-27 | ||
| PCT/US2019/053026 WO2020069037A1 (fr) | 2018-09-26 | 2019-09-25 | Lunettes dotées de caméras à trous d'épingle et à fentes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172745A Division JP2023171481A (ja) | 2018-09-26 | 2023-10-04 | ピンホールおよびスリットカメラを伴うアイウェア |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022502703A JP2022502703A (ja) | 2022-01-11 |
| JPWO2020069037A5 true JPWO2020069037A5 (fr) | 2023-10-19 |
| JP7376578B2 JP7376578B2 (ja) | 2023-11-08 |
Family
ID=69953289
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516924A Active JP7376578B2 (ja) | 2018-09-26 | 2019-09-25 | ピンホールおよびスリットカメラを伴うアイウェア |
| JP2023172745A Pending JP2023171481A (ja) | 2018-09-26 | 2023-10-04 | ピンホールおよびスリットカメラを伴うアイウェア |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023172745A Pending JP2023171481A (ja) | 2018-09-26 | 2023-10-04 | ピンホールおよびスリットカメラを伴うアイウェア |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220011578A1 (fr) |
| EP (1) | EP3857289A4 (fr) |
| JP (2) | JP7376578B2 (fr) |
| CN (1) | CN113168008A (fr) |
| WO (1) | WO2020069037A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3908876A4 (fr) * | 2019-01-11 | 2022-03-09 | Magic Leap, Inc. | Affichage multiplexé dans le temps d'un contenu virtuel à diverses profondeurs |
| EP3997867A4 (fr) * | 2019-07-12 | 2022-09-07 | Magic Leap, Inc. | Système de caméra oculaire et procédés d'étalonnage de système d'affichage |
| US12001017B1 (en) * | 2021-05-17 | 2024-06-04 | Meta Platforms Technologies, Llc | Illumination system for object tracking |
| WO2023075291A1 (fr) * | 2021-10-25 | 2023-05-04 | Samsung Electronics Co., Ltd. | Dispositif d'imagerie dans l'air et son procédé de fonctionnement, système optique de projection pour dispositif d'imagerie dans l'air, système d'affichage d'imagerie dans l'air à interaction, procédé de fonctionnement du système d'affichage d'imagerie dans l'air à interaction |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2215513B1 (fr) * | 2007-10-18 | 2015-05-20 | BAE Systems PLC | Améliorations apportées à des systèmes de visiocasque ou y étant associées |
| JP5295714B2 (ja) | 2008-10-27 | 2013-09-18 | 株式会社ソニー・コンピュータエンタテインメント | 表示装置、画像処理方法、及びコンピュータプログラム |
| DE102009009367B4 (de) * | 2009-02-18 | 2018-01-11 | Schott Ag | Lichtleiter zur Übertragung von Strahlung sowie Herstellverfahren |
| US9028123B2 (en) * | 2010-04-16 | 2015-05-12 | Flex Lighting Ii, Llc | Display illumination device with a film-based lightguide having stacked incident surfaces |
| EP3211299A1 (fr) * | 2012-10-24 | 2017-08-30 | SeeReal Technologies S.A. | Dispositif d'éclairage |
| DE102013216566A1 (de) * | 2013-08-21 | 2015-02-26 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und verfahren zur erfassung einer zumindest teilweise spiegelnden oberfläche |
| JP6349660B2 (ja) | 2013-09-18 | 2018-07-04 | コニカミノルタ株式会社 | 画像表示装置、画像表示方法、および画像表示プログラム |
| US9474902B2 (en) | 2013-12-31 | 2016-10-25 | Nano Retina Ltd. | Wearable apparatus for delivery of power to a retinal prosthesis |
| JP2015194549A (ja) | 2014-03-31 | 2015-11-05 | セイコーエプソン株式会社 | 光学デバイス、画像投影装置及び電子機器 |
| US9606354B2 (en) * | 2014-07-17 | 2017-03-28 | Google Inc. | Heads-up display with integrated display and imaging system |
| CN107530034A (zh) * | 2015-03-16 | 2018-01-02 | 奇跃公司 | 增强现实脉冲血氧定量法 |
| US10334154B2 (en) * | 2015-08-31 | 2019-06-25 | Snap Inc. | Automated adjustment of digital image capture parameters |
| US9964768B2 (en) * | 2016-03-04 | 2018-05-08 | Sharp Kabushiki Kaisha | Head mounted display using spatial light modulator to generate a holographic image |
| US10732414B2 (en) | 2016-08-17 | 2020-08-04 | Microsoft Technology Licensing, Llc | Scanning in optical systems |
| NZ750551A (en) | 2016-08-22 | 2023-05-26 | Magic Leap Inc | Multi-layer diffractive eyepiece |
| US10553139B2 (en) * | 2016-11-10 | 2020-02-04 | Microsoft Technology Licensing, Llc | Enhanced imaging system for linear micro-displays |
| US10222620B2 (en) | 2017-02-15 | 2019-03-05 | Microsoft Technology Licensing, Llc | Pupil-expansion optic with offset entry apertures |
| KR20190132507A (ko) * | 2017-04-06 | 2019-11-27 | 콘스탄틴 로가츠 | 증강 현실(ar) 안경 및 적어도 하나의 안경 렌즈를 통해 안경의 착용자가 볼 수 있는 이미지에 가상 이미지들을 혼합하기 위한 방법 |
-
2019
- 2019-09-25 JP JP2021516924A patent/JP7376578B2/ja active Active
- 2019-09-25 WO PCT/US2019/053026 patent/WO2020069037A1/fr unknown
- 2019-09-25 US US17/279,428 patent/US20220011578A1/en active Pending
- 2019-09-25 CN CN201980077143.3A patent/CN113168008A/zh active Pending
- 2019-09-25 EP EP19864094.8A patent/EP3857289A4/fr active Pending
-
2023
- 2023-10-04 JP JP2023172745A patent/JP2023171481A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7444861B2 (ja) | 屈折力を有する回折光学要素 | |
| JP7280250B2 (ja) | 眼および／または環境の画像を捕捉するように構成される導波管を伴う拡張現実ディスプレイ | |
| US11828946B2 (en) | Systems and methods for retinal imaging and tracking | |
| JP7376578B2 (ja) | ピンホールおよびスリットカメラを伴うアイウェア | |
| US11846778B2 (en) | System for providing illumination of the eye | |
| US20230393398A1 (en) | System for collecting light | |
| JPWO2020069037A5 (fr) |